Regencell Bioscience's total assets for Q4 2025 were $5.76M, a decrease of -23.05% from the previous quarter. RGC total liabilities were $895.31K for the fiscal quarter, a 17.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.